BHC

Bausch Health Companies Inc.

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Bausch Health Companies Inc. (BHC) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B (3.4) C+ (2.5) B- (2.9) B (3.5) C+ (2.6) B- (3.0)
2026-11-10 B (3.4) C+ (2.5) B- (2.9) B (3.5) C+ (2.6) B- (3.0)
2026-11-03 B (3.4) C (2.5) B- (2.9) B (3.2) C+ (2.7) B- (2.9)
2026-10-27 B (3.4) C (2.3) B+ (3.8) B (3.2) C+ (2.6) B- (3.1)
2026-10-20 B (3.4) C (2.2) B+ (3.8) B- (3.1) C+ (2.6) B- (3.0)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe